Independent director Li Liang of EMTEK(Shenzhen)Co., Ltd. (stock code: 300938.SZ) is subject to criminal punishment.

21:20 16/06/2026

Sincerity Measurement and Control Standard (300938.SZ) issued an announcement, the company recently received a notice from Mr. Li Liangren, an independent director of the company, stating that Mr. Li Liangren was sentenced to one month of detention and two months of probation (the probationary period will be from June 9, 2026 to August 9, 2026) for the crime of dangerous driving according to the "Criminal Judgment" (2026) Qiong0108 Criminal Case No. 256 issued by the People's Court of Meilan District, Haikou City, and was fined two thousand yuan. As of now, the company's daily operations are all normal.

EMTEK (Shenzhen) Co., Ltd. (300938.SZ) announced that the company recently received a notice from its independent director, Mr. Li Liangren, that according to the criminal judgment issued by the Meilan District People's Court in Haikou ((2026) Qiong 0108 Criminal First 256), Mr. Li Liangren was sentenced to one month of detention and two months of probation (with the probationary period lasting from June 9, 2026 to August 9, 2026) for the crime of dangerous driving, and was also fined two thousand yuan. As of now, the company's daily operations are proceeding as usual.

IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.

Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.

Jiangsu Hengrui Pharmaceuticals' independently developed CDK4/6 inhibitor hydroxyethyl sulfonate dalsalic tablets has received approval for new indications by the National Medical Products Administration.

IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.

Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.